Thermo Fisher Scientific (TMO) Competitors $485.62 +0.83 (+0.17%) Closing price 08/14/2025 03:59 PM EasternExtended Trading$486.22 +0.60 (+0.12%) As of 06:13 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TMO vs. MEDP, A, AMN, DHR, HAE, MCK, QGEN, WST, MTD, and WATShould you be buying Thermo Fisher Scientific stock or one of its competitors? The main competitors of Thermo Fisher Scientific include Medpace (MEDP), Agilent Technologies (A), AMN Healthcare Services (AMN), Danaher (DHR), Haemonetics (HAE), McKesson (MCK), Qiagen (QGEN), West Pharmaceutical Services (WST), Mettler-Toledo International (MTD), and Waters (WAT). These companies are all part of the "medical" sector. Thermo Fisher Scientific vs. Its Competitors Medpace Agilent Technologies AMN Healthcare Services Danaher Haemonetics McKesson Qiagen West Pharmaceutical Services Mettler-Toledo International Waters Thermo Fisher Scientific (NYSE:TMO) and Medpace (NASDAQ:MEDP) are both large-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends. Which has more volatility & risk, TMO or MEDP? Thermo Fisher Scientific has a beta of 0.74, indicating that its share price is 26% less volatile than the S&P 500. Comparatively, Medpace has a beta of 1.42, indicating that its share price is 42% more volatile than the S&P 500. Do insiders and institutionals have more ownership in TMO or MEDP? 89.2% of Thermo Fisher Scientific shares are owned by institutional investors. Comparatively, 78.0% of Medpace shares are owned by institutional investors. 0.3% of Thermo Fisher Scientific shares are owned by company insiders. Comparatively, 20.3% of Medpace shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Is TMO or MEDP more profitable? Medpace has a net margin of 18.74% compared to Thermo Fisher Scientific's net margin of 15.24%. Medpace's return on equity of 67.66% beat Thermo Fisher Scientific's return on equity.Company Net Margins Return on Equity Return on Assets Thermo Fisher Scientific15.24% 16.82% 8.38% Medpace 18.74%67.66%21.86% Do analysts rate TMO or MEDP? Thermo Fisher Scientific presently has a consensus target price of $593.00, indicating a potential upside of 22.11%. Medpace has a consensus target price of $406.60, indicating a potential downside of 11.35%. Given Thermo Fisher Scientific's stronger consensus rating and higher possible upside, research analysts plainly believe Thermo Fisher Scientific is more favorable than Medpace.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Thermo Fisher Scientific 0 Sell rating(s) 6 Hold rating(s) 15 Buy rating(s) 0 Strong Buy rating(s) 2.71Medpace 3 Sell rating(s) 9 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.93 Which has better valuation and earnings, TMO or MEDP? Thermo Fisher Scientific has higher revenue and earnings than Medpace. Thermo Fisher Scientific is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioThermo Fisher Scientific$42.88B4.28$6.34B$17.2928.09Medpace$2.11B6.11$404.39M$13.4534.10 Does the media prefer TMO or MEDP? In the previous week, Thermo Fisher Scientific had 50 more articles in the media than Medpace. MarketBeat recorded 63 mentions for Thermo Fisher Scientific and 13 mentions for Medpace. Medpace's average media sentiment score of 1.57 beat Thermo Fisher Scientific's score of 1.48 indicating that Medpace is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Thermo Fisher Scientific 57 Very Positive mention(s) 3 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Medpace 11 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive SummaryThermo Fisher Scientific and Medpace tied by winning 8 of the 16 factors compared between the two stocks. Get Thermo Fisher Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for TMO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TMO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TMO vs. The Competition Export to ExcelMetricThermo Fisher ScientificMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket Cap$183.06B$7.00B$5.61B$21.04BDividend Yield0.35%1.30%4.61%3.56%P/E Ratio28.0925.4830.2928.02Price / Sales4.2873.48470.6157.05Price / Cash16.1421.9738.2123.95Price / Book3.635.388.865.26Net Income$6.34B$176.29M$3.25B$994.11M7 Day Performance5.26%3.21%3.72%2.09%1 Month Performance16.09%1.49%5.86%2.35%1 Year Performance-19.56%10.20%30.49%13.36% Thermo Fisher Scientific Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TMOThermo Fisher Scientific4.9655 of 5 stars$485.62+0.2%$593.00+22.1%-19.3%$183.06B$42.88B28.09125,000Positive NewsAnalyst RevisionMEDPMedpace4.3318 of 5 stars$449.51+3.5%$406.60-9.5%+19.1%$12.61B$2.11B33.375,900Positive NewsAAgilent Technologies4.855 of 5 stars$114.43-0.2%$139.77+22.1%-12.6%$32.50B$6.51B28.2517,900Positive NewsAMNAMN Healthcare Services4.3616 of 5 stars$16.57-3.9%$30.25+82.6%-64.5%$633.62M$2.85B-2.132,968Analyst ForecastDHRDanaher4.7987 of 5 stars$199.85-0.4%$247.61+23.9%-21.5%$143.12B$23.88B42.5363,000Positive NewsAnalyst RevisionHAEHaemonetics4.9267 of 5 stars$52.62-2.5%$85.18+61.9%-28.6%$2.53B$1.35B16.103,023MCKMcKesson4.5095 of 5 stars$676.20+1.1%$718.73+6.3%+22.0%$84.19B$359.05B26.9945,000Positive NewsAnalyst ForecastQGENQiagen3.6648 of 5 stars$47.91-0.3%$49.69+3.7%+9.4%$10.65B$1.98B28.325,765WSTWest Pharmaceutical Services4.7128 of 5 stars$240.59-0.2%$320.71+33.3%-15.7%$17.30B$2.96B36.0210,600Positive NewsMTDMettler-Toledo International4.0116 of 5 stars$1,261.49+0.4%$1,288.89+2.2%-6.2%$26.02B$3.87B31.9917,300Positive NewsInsider TradeWATWaters4.8042 of 5 stars$279.97-0.4%$378.73+35.3%-12.8%$16.66B$3.05B25.257,600Trending News Related Companies and Tools Related Companies Medpace Alternatives Agilent Technologies Alternatives AMN Healthcare Services Alternatives Danaher Alternatives Haemonetics Alternatives McKesson Alternatives Qiagen Alternatives West Pharmaceutical Services Alternatives Mettler-Toledo International Alternatives Waters Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:TMO) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Thermo Fisher Scientific Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Thermo Fisher Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access